The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye Complications

▴ Eye Complications Post-Miltefosine Treatment
Numerous cases of eye complications post-miltefosine treatment have emerged, shedding light on the severity of this issue

In recent years, India has made significant waves in combating Kala-azar, a parasitic disease, achieving the elimination target in 2024. However, a concerning revelation has emerged regarding the treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL) using the drug Miltefosine. This treatment, while effective against PKDL, has been associated with severe eye problems, including blindness, prompting urgent attention and further investigation.

Understanding Kala-azar and its Skin Manifestation: Kala-azar, scientifically known as Visceral Leishmaniasis, is a neglected tropical disease caused by the parasite Leishmania donovani, transmitted through the bite of female sand flies. With symptoms such as fever, weight loss, anemia, and enlarged spleen and liver, If left untreated, Kala-azar can be fatal. Post-Kala-azar Dermal Leishmaniasis (PKDL) is a skin manifestation of Kala-azar, affecting about 5-10% of treated patients. Though seemingly harmless, PKDL harbours the parasite, posing a risk of disease transmission within the community.

The Miltefosine Saga: Miltefosine, originally an anticancer drug, is the primary treatment for PKDL. However, recent studies have raised concerns about its association with adverse ocular events, including corneal damage and blindness. The World Health Organization (WHO) and Indian government have acknowledged this issue, prompting the formulation of guidelines for healthcare providers.

Unveiling Eye Complications: Numerous cases of eye complications post-miltefosine treatment have emerged, shedding light on the severity of this issue. Patients have reported symptoms such as eye pain, inflammation, and photophobia, ultimately leading to vision loss. Despite efforts to address these complications, access to timely and appropriate eye care remains a challenge, particularly for rural and marginalized communities.

The Role of Medical Professionals: Ophthalmologists and clinicians have been at the forefront of diagnosing and managing these eye complications. Through diligent observation and treatment, they strive to mitigate the impact of miltefosine-induced ocular damage. However, the success of interventions such as corneal implants hinges on factors such as early detection and follow-up care.

Challenges and Solutions: Limited awareness among healthcare providers and patients, coupled with logistical constraints, pose significant challenges in addressing this issue effectively. Collaborative efforts are needed to enhance awareness, facilitate timely eye examinations, and provide access to specialized care for affected individuals.

Towards a Safer Future: While the road ahead may be fraught with challenges, ongoing research and collaborative initiatives offer hope for reducing the adverse effects of miltefosine treatment. By prioritizing patient safety and leveraging multidisciplinary expertise, we can strive towards safer and more effective treatment strategies for Kala-azar and its complications.

Note: This article draws inspiration from the findings presented in the report by IndiaSpend.org.

Tags : #

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026